A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.

Clinical trial NCT01958957 · COMPLETED

Trial details

NCT number: NCT01958957
Sponsor: Jiangsu Kanion Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Ischemic Stroke

Start date: 2013-06-01
Primary completion: 2014-10-01
Enrollment: 6300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.